Skip to main content
Clinical Trials/NCT02664545
NCT02664545
Active, Not Recruiting
N/A

A Prospective, Randomized, Controlled, Clinical Trial Evaluating the Non-Inferiority of Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR) to Anterior Cruciate Ligament Reconstruction With an Autologous Tendon Graft (ACLR)

Miach Orthopaedics1 site in 1 country100 target enrollmentApril 1, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Tear
Sponsor
Miach Orthopaedics
Enrollment
100
Locations
1
Primary Endpoint
International Knee Documentation Committee (IKDC) Subjective
Status
Active, Not Recruiting
Last Updated
4 months ago

Overview

Brief Summary

The goal of this trial is to compare the efficacy of the Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR™) technique with the current method of treatment for anterior cruciate ligament (ACL) injuries, ACL reconstruction.

Detailed Description

Enrolled patients will be randomized to either the Bridge-Enhanced ACL Repair (BEAR) technique (new treatment) or an ACL reconstruction (current gold standard of treatment).

Registry
clinicaltrials.gov
Start Date
April 1, 2016
End Date
May 31, 2028
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Miach Orthopaedics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age: 14 to 35 years of age.
  • Sex: Both male and female
  • ACL: Complete tear
  • Time from injury to surgery: ≤45 days
  • MRI: ACL tissue present on pre-operative MRI - at least 50% of the ACL length must still be attached to the tibial plateau

Exclusion Criteria

  • Prior surgery on affected knee
  • Prior joint infection on affected knee
  • Regular use of tobacco or nicotine
  • Use of corticosteroid within last 3 months
  • History of chemotherapy treatment
  • History of sickle cell disease
  • History of anaphylaxis
  • Any condition that could affect healing or infection risk (Diabetes, inflammatory arthritis, etc)
  • Operative posterolateral corner injury (LCL complete tear, Biceps femoris tendon avulsion, tear of the arcuate ligament, tear of the popliteus ligament)
  • Grade III medial collateral ligament injury

Outcomes

Primary Outcomes

International Knee Documentation Committee (IKDC) Subjective

Time Frame: 2 years after surgery

This is a survey taken by patients to report how their knee is working for them. The IKDC is graded by adding the results and converting the result to a number on a scale from 0 to 100. Scores range from 0 (lowest level of function and highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Instrumented Anteroposterior (AP) Laxity Testing

Time Frame: 2 years after surgery

This is a test of how stable the knee is. The anteroposterior (AP) knee laxity will be determined using a KT arthrometer at the 30lb (130N) setting on both knees of the subject at six months and 1, 2, 6 and 10 years after surgery (see Appendix C). Both sides will be covered with a sleeve so the licensed examiner cannot tell which is the operated knee or which procedure the patient had. Values for both knees will be recorded. For knee laxity, a difference of 2.0 mm in the side-to-side difference measurements at 2 years after surgery, the primary analysis, for the patients in the bridge-enhanced repair group vs. the ACL reconstruction group will be considered clinically significant.

Secondary Outcomes

  • Prone Hamstring Strength at 6 Months(6 months)
  • Return to Sport (RSI) Patient Reported Outcomes Score at 6 Months.(6 months)

Study Sites (1)

Loading locations...

Similar Trials